Robert Loberg

Robert Loberg, PhD
Vice President and Lifecycle Leader, Oncology & Genetics at Roche Diagnostics

Robert Loberg is Vice President and Lifecycle Leader, Oncology & Genetics at Roche Diagnostics. In his role, Robert oversees development and commercialization of the Next Generation Sequencing & PCR portfolio assay and menu content. In addition, Robert heads the molecular Pharma Partnering & Services Business, oversees the Roche San Jose CAP/CLIA laboratory, and is the Site Head for Roche Signature Diagnostics in Potsdam, Germany.

Robert has experience across a broad range of R&D and commercial activities at both BioPharma and Diagnostics companies. Prior to joining Roche, Robert spent 13 years at Amgen in various roles, ending his time at Amgen leading the Clinical Biomarker and Diagnostics efforts within R&D. His experience in development, regulatory approval, and market access has led toa record of delivering strategies that support a broad portfolio of pharmaceutical and diagnosticproducts. With more than 50 peer-reviewed publications and considerable hands-on lab work,Robert has demonstrated a passion for translational research and its applications in cancer therapeutics.

Robert received his PhD in Physiology from the University of Michigan where he also served as an Assistant Professor holding joint appointments in the Departments of Internal Medicine and Urology.